{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:39:24Z","timestamp":1784165964234,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Wendy Feuer Fund for the Prevention and Treatment of Ovarian Cancer"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10689-020-00166-5","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T08:05:45Z","timestamp":1582531545000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-8501","authenticated-orcid":false,"given":"Talayeh S.","family":"Ghezelayagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy J.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"166_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A et al (2016) Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKTOCS): a randomized controlled trial. Lancet 387:945\u2013956","journal-title":"Lancet"},{"key":"166_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","volume":"143","author":"PF Pinsky","year":"2016","unstructured":"Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC (2016) Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol Oncol 143:270\u2013275","journal-title":"Gynecol Oncol"},{"key":"166_CR3","unstructured":"National Comprehensive Cancer Network (NCCN) (2019) NCCN Guidelines Version 3.2019 Genetic\/Familial High-Risk Assessment: Breast and Ovarian. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed 10 May 2019"},{"key":"166_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967\u2013975","journal-title":"JAMA"},{"key":"166_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1940-6207.CAPR-11-0430","volume":"5","author":"AM McCarthy","year":"2010","unstructured":"McCarthy AM, Menke A, Ouyang P, Visvanathan K (2010) Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older. Cancer Prev Res (Phila) 5:847\u2013854","journal-title":"Cancer Prev Res (Phila)"},{"key":"166_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","volume":"113","author":"WH Parker","year":"2009","unstructured":"Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses\u2019 health study. Obstet Gynecol 113:1027\u20131037","journal-title":"Obstet Gynecol"},{"key":"166_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","volume":"153","author":"S Gordhandas","year":"2019","unstructured":"Gordhandas S, Norwuist BM, Pennington KP, Yung RL, Laya MB, Swisher EM (2019) Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits. Gynecol Oncol 153:192\u2013200","journal-title":"Gynecol Oncol"},{"key":"166_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","volume":"69","author":"WA Rocca","year":"2007","unstructured":"Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ III (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69:1074\u20131083","journal-title":"Neurology"},{"key":"166_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","volume":"7","author":"WA Rocca","year":"2006","unstructured":"Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ III (2006) Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7:821\u2013828","journal-title":"Lancet Oncol"},{"key":"166_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1006\/gyno.2002.6779","volume":"81","author":"K Leeper","year":"2002","unstructured":"Leeper K, Garca R, Swisher E, Goff B, Greer B, Paley P (2002) Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 81:52\u201356","journal-title":"Gynecol Oncol"},{"key":"166_CR11","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","volume":"18","author":"KH Lu","year":"2002","unstructured":"Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG (2002) Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol 18:2728\u20132732","journal-title":"J Clin Oncol"},{"key":"166_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","volume":"106","author":"I Cass","year":"2005","unstructured":"Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY (2005) BRCA-mutation-associated fallopian tube carcinoma: distinct clinical phenotype? Obstet Gynecol 106:1327\u20131334","journal-title":"Obstet Gynecol"},{"key":"166_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/gyno.2000.6071","volume":"80","author":"PJ Paley","year":"2001","unstructured":"Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA (2001) Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 80:176\u2013180","journal-title":"Gynecol Oncol"},{"key":"166_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","volume":"194","author":"JD Lamb","year":"2006","unstructured":"Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM (2006) Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol 194:1702\u20131709","journal-title":"Am J Obstet Gynecol"},{"key":"166_CR15","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","volume":"32","author":"ME Sherman","year":"2014","unstructured":"Sherman ME, Piedmonte M, Mai PL et al (2014) Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol 32:3275\u20133283","journal-title":"J Clin Oncol"},{"key":"166_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","volume":"129","author":"CB Powell","year":"2013","unstructured":"Powell CB, Swisher EM, Cass I, McLennan J, Norquist B, Garcia RL, Lester J, Karlan BY, Chen L (2013) Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol 129:364\u2013371","journal-title":"Gynecol Oncol"},{"key":"166_CR17","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","volume":"18","author":"KH Lu","year":"2000","unstructured":"Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG (2000) Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol 18:2728\u20132732","journal-title":"J Clin Oncol"},{"key":"166_CR18","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25:3985\u20133990","journal-title":"J Clin Oncol"},{"key":"166_CR19","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","volume":"26","author":"JW Carlson","year":"2008","unstructured":"Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberge D, Crum CP (2008) Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 26:4160\u20134165","journal-title":"J Clin Oncol"},{"key":"166_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","volume":"13","author":"Y Lee","year":"2006","unstructured":"Lee Y, Medeiros F, Kinderberger D, Callagan MJ, Muto MG, Crum CM (2006) Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol 13:1\u20137","journal-title":"Adv Anat Pathol"},{"key":"166_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211:26\u201335","journal-title":"J Pathol"},{"key":"166_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1593\/neo.101044","volume":"12","author":"JZ Press","year":"2010","unstructured":"Press JZ, Wurz K, Norquist BM, Lee MK, Pennil C, Garcia R, Welcsh P, Goff BA, Swisher EM (2010) Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers. Neoplasia 12:993\u20131002","journal-title":"Neoplasia"},{"key":"166_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy SI, Papp E, Hallberg D et al (2017) High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun 8:1093","journal-title":"Nat Commun"},{"key":"166_CR24","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1002\/cncr.25439","volume":"116","author":"BM Norquist","year":"2010","unstructured":"Norquist BM, Garcia RL, Allison KH, Jokinen CH, Kernochan LE, Pizzi CC, Barrow BJ, Goff BA, Swisher EM (2010) The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. Cancer 116:5261\u20135271","journal-title":"Cancer"},{"key":"166_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","volume":"150","author":"DR Nebgen","year":"2018","unstructured":"Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH (2018) Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1\/2 mutations. Gynecol Oncol 150:79\u201384 ()","journal-title":"Gynecol Oncol"},{"key":"166_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","volume":"15","author":"MG Harmsen","year":"2015","unstructured":"Harmsen MG, Arts-de Jong M, Hoogerbrugge N et al (2015) Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study. BMC Cancer 15:593","journal-title":"BMC Cancer"},{"key":"166_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"166_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/occmed\/kqu024","volume":"64","author":"AF Stern","year":"2014","unstructured":"Stern AF (2014) The hospital anxiety and depression scale. Occup Med 64:393\u2013394","journal-title":"Occup Med"},{"key":"166_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ygyno.2017.02.008","volume":"145","author":"PL Mai","year":"2017","unstructured":"Mai PL, Piedmonte M, Han PK et al (2017) Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: an NRG Oncology\/Gynecologic Oncology Group study. Gynecol Oncol 145:122\u2013129","journal-title":"Gynecol Oncol"},{"key":"166_CR30","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"166_CR31","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes, Dr et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416","journal-title":"JAMA"},{"key":"166_CR32","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105:812\u2013822","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"166_CR33","doi-asserted-by":"publisher","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","volume":"107","author":"H Falconer","year":"2015","unstructured":"Falconer H, Yin L, Gronberg H, Altman D (2015) Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst 107(2):dju410","journal-title":"J Natl Cancer Inst"},{"key":"166_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:161\u2013169","journal-title":"Am J Surg Pathol"},{"key":"166_CR35","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/modpathol.2013.212","volume":"27","author":"MJ Mingels","year":"2014","unstructured":"Mingels MJ, van Ham MA, de Kievit IM et al (2014) Mullerian precursor lesions in serous ovarian cancer patients: using the SEE-FIM and SEE-END protocol. Mod Pathol 27:1002\u20131013","journal-title":"Mod Pathol"},{"key":"166_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ygyno.2017.04.015","volume":"146","author":"EE Meserve","year":"2017","unstructured":"Meserve EE, Mirkovic J, Conner JR et al (2017) Frequency of \u201cincidental\u201d serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study. Gynecol Oncol 146:69\u201373","journal-title":"Gynecol Oncol"},{"key":"166_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1399-0004.2008.01117.x","volume":"75","author":"A Finch","year":"2009","unstructured":"Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S (2009) Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene. Clin Genet 75:220\u2013224","journal-title":"Clin Genet"},{"key":"166_CR38","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10897-017-0072-0","volume":"26","author":"G Cicero","year":"2017","unstructured":"Cicero G, De Luca R, Dorangricchia P, Lo Coco G, Guarnaccia C, Fanale D, Calo V, Russo A (2017) Risk perception and psychological distress in genetic counselling for hereditary breast and\/or ovarian cancer. J Genet Couns 26:999\u20131007","journal-title":"J Genet Couns"},{"key":"166_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/pon.3560","volume":"24","author":"A Tong","year":"2014","unstructured":"Tong A, Kelly S, Nusbaum R, Graves K, Peshkin BN, Valdimarsdottir HB, Wood M, McKinnon W, Garber J, McCormick SR, Jandorf L, Schwartz MD (2014) Intentions for risk-reducing surgery among high-risk women referred for BRCA1\/BRCA2 genetic counseling. Psychooncology 24:33\u201339","journal-title":"Psychooncology"},{"key":"166_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1037\/hea0000156","volume":"34","author":"DB Portnoy","year":"2015","unstructured":"Portnoy DB, Loud JT, Han PK, Mai PL, Greene MH (2015) Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1\/2 carriers. Health Psychol 34:709\u2013717","journal-title":"Health Psychol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00166-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-020-00166-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00166-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:26:11Z","timestamp":1614039971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-020-00166-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1007\/s10689-020-00166-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}